FDA Approved Products
6,646 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
ANTHELIOS 20
avobenzone; ecamsule; octocrylene; titanium dioxide
LOE Approaching
TOPICAL · CREAM
Sunburnswind burned+1
2006
NDA30/100
ANTHELIOS 40
avobenzone; ecamsule; octocrylene; titanium dioxide
LOE Approaching
TOPICAL · CREAM
sunburn if useddecreases the risk of skin cancer+1
2008
NDA30/100
ANTHELIOS SX
avobenzone; ecamsule; octocrylene
LOE Approaching
TOPICAL · CREAM
Sunburnswind burned+1
2006
NDA30/100
ANTIVERT
meclizine hydrochloride
LOE Approaching
R-Pharm US
ORAL · TABLET
vertigo associated with diseases affecting the vestibular system in adults
1957
NDA30/100
ANTURANE
sulfinpyrazone
LOE Approaching
Novartis
ORAL · TABLET
1959
NDA30/100
ANZEMET
dolasetron mesylate
LOE Approaching
Bausch Health
INJECTION · INJECTABLE
nauseavomiting associated with moderately emetogenic cancer chemotherapy+4
1997
NDA30/100
ANZEMET
dolasetron mesylate
LOE Approaching
Bausch Health
ORAL · TABLET
nauseavomiting associated with moderately emetogenic cancer chemotherapy+4
1997
NDA30/100
APHTHASOL
amlexanox
LOE Approaching
DENTAL · PASTE
1996
NDA30/100
APOKYN
apomorphine hydrochloride
LOE Approaching
SUBCUTANEOUS · INJECTABLE
Parkinson's disease
2004
NDA30/100
APRESOLINE
hydralazine hydrochloride
LOE Approaching
Novartis
ORAL · TABLET
hypertension
1953
NDA30/100
APTENSIO XR
methylphenidate hydrochloride
Peak
ORAL · CAPSULE, EXTENDED RELEASE
Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 yearsolder
2015
NDA30/100
APTIVUS
tipranavir
LOE Approaching
Boehringer Ingelheim
ORAL · SOLUTION
hepatitis B
2008
SMNDA30/100
APTIVUS
tipranavir
LOE Approaching
Boehringer Ingelheim
ORAL · CAPSULE
hepatitis B
2005
SMNDA30/100
APTIVUS
tipranavir
LOE Approaching
Boehringer Ingelheim
ORAL · SOLUTION
hepatitis B
2008
SMNDA30/100
AQUAMEPHYTON
phytonadione
LOE Approaching
R-Pharm US
INJECTION · INJECTABLE
the following coagulation disorders which are due to faulty formation of factors IIinterference with vitamin K activity: • anticoagulant-induced hypoprothrombinemia caused by coumarin+2
1960
NDA30/100
AQUASOL A
water-miscible retinyl palmitate
LOE Approaching
R-Pharm US
INJECTION · INJECTABLE
1949
NDA30/100
AQUATAG
benzthiazide
LOE Approaching
ORAL · TABLET
1965
NDA30/100
AQUATENSEN
methyclothiazide
LOE Approaching
Bausch Health
ORAL · TABLET
1977
NDA30/100
ARALEN
chloroquine phosphate
LOE Approaching
Sanofi
ORAL · TABLET
1949
NDA30/100
ARALEN HYDROCHLORIDE
chloroquine hydrochloride
LOE Approaching
Sanofi
INJECTION · INJECTABLE
1949
NDA30/100
ARALEN PHOSPHATE W/ PRIMAQUINE PHOSPHATE
chloroquine phosphate; primaquine phosphate
LOE Approaching
Sanofi
ORAL · TABLET
1968
NDA30/100
ARAMINE
metaraminol bitartrate
LOE Approaching
Merck & Co.
INJECTION · INJECTABLE
1954
NDA30/100
ARAVA
leflunomide
LOE Approaching
Sanofi
ORAL · TABLET
rheumatoid arthritis
1998
NDA30/100
ARDUAN
pipecuronium bromide
LOE Approaching
Merck & Co.
INJECTION · INJECTABLE
1990
NDA30/100